|
18th International Workshop on Kaposi's sarcoma herpesvirus and related agents
|
1R13CA196357-01
|
$9,000
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$247,753
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-02
|
$699,896
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
AIDS Malignancy Consortium (AMC)
|
2UM1CA121947-09
|
$13,134,493
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,007,151
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-02
|
$780,706
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$561,071
|
Steinberg, Seth
|
CCR (NCI)
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S1
|
$62,499
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S2
|
$47,351
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S4
|
$31,250
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S5
|
$59,750
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-39
|
$6,790,080
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016042-40S1
|
$62,499
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
5P30CA016042-40
|
$4,295,192
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
2P30CA047904-27
|
$5,129,654
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-27S2
|
$115,192
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-27S3
|
$60,000
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
5U54CA190155-02
|
$699,003
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150 - 10362
|
$239,197
|
Engels, Eric
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$294,084
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$979,999
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies cause
|
1R21CA189703-01A1
|
$167,475
|
QU, ZHAOXIA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$251,924
|
Burke, Terrence
|
CCR (NCI)
|
|
Development of a Small Molecule Inhibitor for KSHV LANA
|
5R01CA186775-02
|
$383,875
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
ZIA BC 011062
|
$243,955
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,951,637
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$243,955
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$33,793
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
|
2R01CA136367-06A1
|
$359,777
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,065,220
|
Pavlakis, George
|
CCR (NCI)
|
|
Early Events in KSVH Infection of Primary B-cells
|
5P01CA174439-03
|
$642,109
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Early events of in vitro KSHV infection
|
5R01CA168472-04
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$811,586
|
Carrington, Mary
|
CCR (NCI)
|
|
Escape from gammaherpesvirus-induced mRNA destruction
|
5R01CA160556-05
|
$309,252
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$550,522
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$865,635
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$290,767
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetic and Biochemical Studies of KSHV LANA
|
2R01CA082036-16A1
|
$420,869
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Persistence of KSHV
|
5R01CA171979-03
|
$298,800
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
|
1R01CA179921-01A1
|
$400,313
|
MOSES, ASHLEE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Herpesviral, Oncogenesis, Latency and Reactivation
|
5P01CA019014-36
|
$1,832,044
|
RAAB-TRAUB, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
HHV-8 vIRF interactions in the context of infection
|
1R21CA196348-01A1
|
$176,175
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150 - 10071
|
$127,100
|
Engels, Eric
|
DCEG (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
|
ZIA BC 010524
|
$256,520
|
Nicklaus, Marc
|
CCR (NCI)
|
|
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment
|
5K23CA150931-05
|
$142,035
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|